| Q37089556 | A fatal neuroinvasive West Nile virus infection in a traveler returning from Madagascar: clinical, epidemiological and veterinary investigations |
| Q34779072 | A hamster-derived West Nile virus isolate induces persistent renal infection in mice |
| Q39349515 | A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell lines |
| Q38156849 | A neutralization assay for Zika and Dengue viruses using a real-time PCR-based endpoint assessment |
| Q40070213 | A probable case of West Nile virus transfusion transmission |
| Q37708659 | A review of the epidemiological and clinical aspects of West Nile virus |
| Q37712155 | Acute flaccid paralysis due to West nile virus infection in adults: A paradigm shift entity |
| Q38131535 | Application of West Nile virus diagnostic techniques |
| Q38008644 | Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex |
| Q40255394 | Arenavirus and West Nile virus in solid organ transplantation. |
| Q50494525 | Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms. |
| Q38078650 | Blood component recalls and market withdrawals: frequency, reasons, and management in the United States |
| Q35138507 | Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease |
| Q37546791 | Characteristics of antibody responses in West Nile virus-seropositive blood donors |
| Q44848371 | Chikungunya virus: new risk to transfusion safety in the Americas. |
| Q98159494 | Clinical Features of Four West Nile Virus Cases and Its Molecular Characterization from a South Indian Tertiary Care Hospital |
| Q92631295 | Comparative Pathology of West Nile Virus in Humans and Non-Human Animals |
| Q42223657 | Considerations for screening live kidney donors for endemic infections: a viewpoint on the UNOS policy |
| Q38203769 | Current developments in understanding of West Nile virus central nervous system disease |
| Q65000498 | Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses. |
| Q40209387 | Detection of West Nile virus lineage 2 in the urine of acute human infections |
| Q38903494 | Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012. |
| Q47550078 | Development and Validation of a Serologic Test Panel for Detection of Powassan Virus Infection in U.S. Patients Residing in Regions Where Lyme Disease Is Endemic |
| Q37271674 | Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies |
| Q47547502 | Diagnostic Testing for Zika Virus: A Post-Outbreak Update |
| Q92427181 | Direct-from-Specimen Pathogen Identification: Evolution of Syndromic Panels |
| Q35922064 | Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto Rico |
| Q38211715 | Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features |
| Q37003076 | Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic |
| Q34418533 | Emerging and reemerging neurologic infections |
| Q33866041 | Emerging viral infections of the central nervous system: part 1. |
| Q34259739 | Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013. |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q40297371 | Estimated prevalence of dengue viremia in Puerto Rican blood donations, 1995 through 2010. |
| Q34694152 | Evidence of West Nile virus infection in Nepal |
| Q97556928 | Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort study |
| Q36096374 | Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control |
| Q40155194 | Fatal West Nile Virus Encephalitis in a Heart Transplant Recipient |
| Q40238754 | Fatal West Nile virus infection after probable transfusion-associated transmission--Colorado, 2012. |
| Q40242280 | Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010. |
| Q27488301 | Frequency of Missed Cases of Probable Acute West Nile Virus (WNV) Infection when Testing for WNV RNA Alone or WNV Immunoglobulin M Alone |
| Q27468998 | High Incidence of Chikungunya Virus and Frequency of Viremic Blood Donations during Epidemic, Puerto Rico, USA, 2014 |
| Q55522996 | Human Usutu Virus Infection with Atypical Neurologic Presentation, Montpellier, France, 2016. |
| Q34770618 | Identification of class I HLA T cell control epitopes for West Nile virus |
| Q90450452 | IgM in human immunity to Plasmodium falciparum malaria |
| Q37629959 | Immune markers associated with host susceptibility to infection with West Nile virus |
| Q33866024 | Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients |
| Q40037551 | Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic |
| Q37434935 | Integrated human surveillance systems of West Nile virus infections in Italy: the 2012 experience |
| Q90788873 | Interpretation of pathogen load in relationship to infectivity and pathogen reduction efficacy |
| Q38228543 | Laboratory diagnosis of viral infection |
| Q38340175 | Latest developments and challenges in the diagnosis of human West Nile virus infection |
| Q97556908 | Learning about Zika virus epidemiology and diagnostics from blood donor studies |
| Q38157219 | Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approach |
| Q37196250 | Mutation in West Nile Virus Structural Protein prM during Human Infection |
| Q40281592 | Neglected infections of poverty in Texas and the rest of the United States: management and treatment options |
| Q90705326 | Neuroinvasive West Nile Virus Post-Heart Transplantation: A Case Report |
| Q27009096 | Neurological approaches for investigating West Nile virus disease and its treatment in rodents |
| Q41135035 | Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile virus Infection |
| Q36909187 | PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation |
| Q33586206 | Persistence of West Nile virus in the central nervous system and periphery of mice |
| Q28804172 | Persistence of Zika Virus in Body Fluids — Preliminary Report |
| Q33798574 | Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection |
| Q27489893 | Progress on the development of therapeutics against West Nile virus |
| Q34424352 | Regulation of cell survival and death during Flavivirus infections |
| Q37082586 | Risk factors for West Nile virus infection and disease in populations and individuals |
| Q41922648 | Severe Neuroinvasive West Nile Virus Infection in a Child with Undiagnosed Addison's Disease. |
| Q90159999 | Single cell immune profiling of dengue virus patients reveals intact immune responses to Zika virus with enrichment of innate immune signatures |
| Q58122913 | Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity |
| Q34784962 | Systems immunology reveals markers of susceptibility to West Nile virus infection |
| Q36252455 | The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability |
| Q22809893 | The role of viral persistence in flavivirus biology |
| Q37845954 | The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere |
| Q37642043 | Transfusion-transmitted arboviruses |
| Q34133145 | Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress |
| Q35097106 | Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention |
| Q38092789 | Update on donor-derived infections in liver transplantation. |
| Q27468797 | Use of Testing for West Nile Virus and Other Arboviruses |
| Q98947195 | Using Climate to Explain and Predict West Nile Virus Risk in Nebraska |
| Q27329490 | Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus |
| Q29364461 | Viral and serological kinetics in Zika virus-infected patients in South Korea |
| Q34237824 | Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals |
| Q40228190 | West Nile Virus Infection in the Immunocompromised Patient |
| Q26865618 | West Nile Virus: biology, transmission, and human infection |
| Q56932479 | West Nile virus |
| Q40290912 | West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic |
| Q38577945 | West Nile virus infection in children |
| Q35229705 | West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012. |
| Q45367860 | West Nile virus neuroinvasive disease presenting with acute flaccid paralysis and bilateral sensorineural hearing loss. |
| Q34718025 | West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety |
| Q37434776 | West Nile virus state of the art report of MALWEST Project |
| Q40326867 | West Nile virus. II. Immunopathophysiology in humans |
| Q26827766 | West Nile virus: review of the literature |
| Q34763947 | West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease |
| Q35181923 | Xenosurveillance: a novel mosquito-based approach for examining the human-pathogen landscape |
| Q78176630 | Zika Virus IgM 25 Months after Symptom Onset, Miami-Dade County, Florida, USA. |
| Q61053662 | Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset |
| Q22250881 | Zika Virus Outbreak on Yap Island, Federated States of Micronesia |
| Q27011235 | Zika fever and congenital Zika syndrome: An unexpected emerging arboviral disease |
| Q97556920 | Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study |
| Q45323553 | Zika virus reservoirs: Implications for transmission, future outbreaks, drug and vaccine development |
Search more.